-
Triacetin, HDACs, and Glioblastoma Cell Death
2026-08-31
The reference study integrates cell-cycle analysis, HDAC and microRNA expression, mTORC2-related transcripts, and molecular modeling to examine how Triacetin and other acetates affect U87MG glioblastoma cells. Its findings support a mechanistic link between acetate exposure, epigenetic regulation, G2/M arrest, and apoptosis, while remaining limited to an in vitro cancer-cell model.
-
AT13387: A Mechanism-First Cancer Assay Guide
2026-08-31
AT13387 is a high-affinity Hsp90 inhibitor for dissecting oncogenic signaling, cell cycle arrest, and apoptosis induction. This guide connects its cancer biology research applications with a norovirus study that clarifies how selective protein release can be distinguished from nonspecific membrane rupture.
-
Metoprolol Tartrate: Designing β1-Specific Assays
2026-08-30
Metoprolol Tartrate enables selective β1-adrenergic receptor inhibition in cardiovascular research while helping investigators separate cardiac effects from hematopoietic confounders. This guide translates transplant evidence into practical assay-design and interpretation decisions.
-
Oridonin, Inflammation, and Esophageal Cancer
2026-08-29
Peng et al. investigated whether oridonin suppresses esophageal cancer through the TLR4/NF-κB/NLRP3 inflammasome axis in a 4-NQO-induced mouse model. The integrated histological, inflammatory, hematological, transcriptional, and protein-level evidence supports an inflammation-centered mechanism, while the preclinical design also defines important limits for translation.
-
Carvacrol in Redox-Sensitive TRP Assays
2026-08-29
Carvacrol, also called 5-isopropyl-2-methylphenol, provides a useful non-electrophilic TRPA1 agonist for separating ligand-specific channel behavior from oxidative modification. This guide converts recent TRPV1/TRPA1 findings into practical calcium-imaging, redox-challenge, cell-cycle, and apoptosis workflows.
-
Nicotine Signaling and CKD Progression in Smokers
2026-08-28
Jain and Jaimes’ review integrates clinical observations with experimental evidence to explain how nicotine may accelerate chronic kidney disease through non-neuronal nicotinic acetylcholine receptors, oxidative stress, hemodynamic changes, and fibrosis. Its main contribution is a mechanistic framework that separates nicotine-mediated signaling from the broader toxicity of cigarette smoke and identifies receptor pathways for further investigation.
-
Busulfan Beyond Damage: Tracing Reproductive Biology
2026-08-28
Busulfan is more than a DNA alkylating agent: it is a controllable perturbation for studying stress signaling, senescence, germ-cell depletion, and the limits of tissue regeneration. This thought-leadership article connects mechanistic biology with dual-recombinase lineage tracing to help translational researchers distinguish cellular injury from genuine neo-oogenesis.
-
HyperScribe T7 Cy5 Kit: Assay Design Guide
2026-08-27
The HyperScribe T7 High Yield Cy5 RNA Labeling Kit enables tunable fluorescent RNA probe synthesis for localization, hybridization, and delivery-biology studies. This guide connects Cy5-UTP incorporation with practical assay decisions inspired by ROS-responsive mRNA delivery research.
-
Ibotenic Acid: Workflows for Neural Disease Models
2026-08-27
Ibotenic acid is an NMDA receptor agonist for building controlled experimental models of glutamatergic dysfunction, circuit injury, and acute neurotoxicity. This guide connects formulation, time-resolved behavioral assays, c-fos and Nissl-body readouts, and troubleshooting strategies for more reproducible neuroscience research.
-
DOPE: From Endosomal Escape to Fungal Biology
2026-08-26
A translational perspective on 1,2-Dioleoyl-sn-glycero-3-PE (DOPE), linking its membrane-fusion mechanism in nucleic acid delivery with lipidomics insights into Magnaporthe oryzae pathogenicity while separating established evidence from forward-looking research strategy.
-
LNP Surface Charge and V-ATPase Drive Nucleic Acid Delivery
2026-08-26
The reference study identifies a synergistic relationship between LNP surface charge and V-ATPase activity in target cells, showing that delivery cannot be predicted from nanoparticle properties alone. Its in vitro, in vivo, pharmacological, genetic, and protein-corona analyses provide a mechanistic framework for interpreting charge-dependent tropism and improving nucleic acid delivery studies.
-
GRK Control of M1 Receptor Signaling Bias
2026-08-25
A 2025 study used dynamic BRET assays to define how GRK2/3 and GRK5/6 differentially regulate M1 muscarinic receptor coupling to G proteins and β-arrestin 2. Its findings position GRK subtype balance, rather than receptor activation alone, as a determinant of M1 signaling bias and clarify how BQCA changes acetylcholine responses.
-
Amphotericin B for Biofilm Research Workflows
2026-08-25
Amphotericin B provides a membrane-directed challenge for dissecting Candida albicans biofilm resistance, while PP2A–autophagy perturbations reveal why susceptibility can shift. This practical guide pairs dose-control, orthogonal readouts, and host-cell safeguards for more interpretable fungal infection research.
-
Multiplexed ACE2 Libraries Map SARS-CoV-2 Receptor Shifts
2026-08-24
Shukla and colleagues developed a pooled pseudotyped-virus assay that uses DNA barcodes to measure how multiple ACE2 sequences support entry by SARS-CoV-2 spike variants. The study shows that variant-associated changes have modest effects on human ACE2 usage but can substantially reshape compatibility with animal ACE2 orthologs, providing a scalable framework for studying receptor tropism.
-
GSK2606414: Practical PERK Inhibitor Workflows
2026-08-23
GSK2606414 is a selective PERK inhibitor for separating translational control from broader ER stress and redox responses. This workflow connects phospho-eIF2α measurements, Nrf2-centered infection biology, and practical assay controls for more interpretable ER stress research.
450 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page